Skip to main content
FinSpry Logo
FinSpry
GMED logo
GMED
(NYSE)
Globus Medical, Inc.
$80.04-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Globus Medical, Inc. (GMED) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Globus Medical, Inc. stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy
Based on 8 unique analysts
Medium Confidence∞:1 Buy/Sell

Average Price Target

$113.29
↑ 41.54% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest GMED Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Matthew O'Brien
Piper Sandler
BuyMaintains
$115.00 → $100.00
Matt Miksic
Barclays
BuyMaintains
$123.00
Caitlin Cronin
Canaccord Genuity
BuyReiterates
$115.00
Richard Newitter
Truist
BuyMaintains
-
Mathew Blackman
TD Cowen
BuyMaintains
$112.00 → $115.00
Larry Biegelsen
Wells Fargo
BuyMaintains
$104.00 → $103.00
David Saxon
Needham
BuyReiterates
$114.00 → $117.00
Shagun Singh Chadha
RBC Capital
BuyMaintains
$115.00 → $120.00

Frequently Asked Questions

What is the analyst consensus rating for GMED?

The analyst consensus rating for GMED is "Buy" based on 8 analyst recommendations.

What is the average price target for GMED?

The average 12-month price target for GMED is $113.29, representing an upside of 41.5% from the current price of $80.04.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.